Back to Feed
ClinicalTrials.gov|Clinical Trial

Anterior Cruciate Ligament (ACL) Reconstruction With Autologous Fat Pad Derived Mesenchymal Stem Cells

The Methodist Hospital Research Institute

Abstract

This study is designed as a prospective, open label, single arm pilot clinical study that will establish the safety and efficacy of a single injection of mesenchymal stromal cells in patients. Each subject will receive one intra-articular injection of autologous mesenchymal stromal cells derived from infrapatellar fat pad (FP-MSC) tissue samples collected from the subject during anterior cruciate ligament (ACL) reconstruction surgery. Phase: PHASE1 Status: RECRUITING Conditions: Anterior Cruciate Ligament Reconstruction Interventions: Autologous Mesenchymal Stromal Cells

Keywords

Anterior Cruciate Ligament Reconstruction
Anterior Cruciate Ligament (ACL) Reconstruction With Autologous Fat Pad Derived Mesenchymal Stem Cells | StemCell Pulse | StemCell Pulse